IL6 and neoplasm: For patients with tumors, tumor cells release a variety of cytokines such as interleukin‐1 (IL‐1), IL‐6, and TNF‐α, which can stimulate osteoclast differentiation via multiple mechanisms and disrupt the balance of bone remodeling [24, 25].